Terms: = Lung cancer AND COX6C, P09669, 1345, ENSG00000164919 AND Treatment
9 results:
1. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Ragni MV; Rothenberger SD; Feldman R; Nance D; Leavitt AD; Malec L; Kulkarni R; Sidonio R; Kraut E; Lasky J; Pruthi R; Angelini D; Philipp C; Hwang N; Wheeler AP; Seaman C; Machin N; Xavier F; Meyer M; Bellissimo D; Humphreys G; Smith KJ; Merricks EP; Nichols TC; Ivanco D; Vehec D; Koerbel G; Althouse AD
Lancet Haematol; 2023 Aug; 10(8):e612-e623. PubMed ID: 37385272
[TBL] [Abstract] [Full Text] [Related]
2. Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell lung cancer.
Chen Y; Wen S; Xia J; Du X; Wu Y; Pan B; Zhu W; Shen B
Front Immunol; 2021; 12():672271. PubMed ID: 34054853
[TBL] [Abstract] [Full Text] [Related]
3. The clinical and pathological features of plasma cell myeloma post solid organ transplantation.
Ofori K; Soderquist CR; Murty VV; Park D; Vlad G; Leeman-Neill RJ; Lentzsch S; Alobeid B; Bhagat G
Am J Hematol; 2020 Dec; 95(12):1531-1541. PubMed ID: 32864761
[TBL] [Abstract] [Full Text] [Related]
4. "Real world survey" of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients.
Chen JB; Kong XF; Lv YY; Qin SC; Sun XJ; Mu F; Lu TY; Xu KC
Med Gas Res; 2019; 9(3):115-121. PubMed ID: 31552873
[TBL] [Abstract] [Full Text] [Related]
5. Pulmonary recurrence in patients with endometrial cancer.
Turan T; Ureyen I; Karalok A; Tasci T; Turkmen O; Kocak O; Koc S; Tulunay G
J Chin Med Assoc; 2016 Apr; 79(4):212-20. PubMed ID: 26874679
[TBL] [Abstract] [Full Text] [Related]
6. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract] [Full Text] [Related]
7. A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Sculier JP; Lafitte JJ; Lecomte J; Berghmans T; Thiriaux J; Van Cutsem O; Efremidis A; Ninane V; Paesmans M; Mommen P; Klastersky J;
Ann Oncol; 2002 Sep; 13(9):1454-9. PubMed ID: 12196372
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospital.
Clerici M; Panvini D; Torri V; Colombo F; Luporini G; Tinazzi A; Nicolucci A; Marsoni S
Tumori; 1994 Apr; 80(2):106-12. PubMed ID: 8016899
[TBL] [Abstract] [Full Text] [Related]
9. [Polychemotherapy for advanced epidermoid cell lung cancer (author's transl)].
Kokron O
Wien Klin Wochenschr; 1982 Jan; 94(1):1-5. PubMed ID: 7080489
[TBL] [Abstract] [Full Text] [Related]
